Synlogic reports second quarter financial results and provides business update

Cambridge, mass., aug. 12, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the second quarter ended june 30, 2021, and provided an update on its clinical and preclinical programs.
SYBX Ratings Summary
SYBX Quant Ranking